Shaheed Beheshti Medical University – Developmental Therapeutics Review – Q4 2010
Summary
Global Market Direct’s pharmaceuticals report, “Shaheed Beheshti Medical University – Developmental Therapeutics Review – Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable).
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.
Scope
Reasons to buy
Summary
Global Market Direct’s pharmaceuticals report, “Shaheed Beheshti Medical University – Developmental Therapeutics Review – Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable).
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.
Scope
- Review of therapeutics under development by Shaheed Beheshti Medical University.
- Overview of products under development across various therapy areas.
- Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Shaheed Beheshti Medical University with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of Shaheed Beheshti Medical University’s therapeutic products in the last quarter.
- Latest news and deals relating to the products.
Reasons to buy
- Identify new drug targets and therapeutic classes in Shaheed Beheshti Medical University’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying opportunities to fill portfolio gaps.
- Evaluate Shaheed Beheshti Medical University’s position with total access to a detailed information on its therapeutic products development.
- Assess the growth potential of Shaheed Beheshti Medical University in its therapy areas of focus.
- Exploit collaboration and partnership opportunities with Shaheed Beheshti Medical University.
- Avoid Intellectual Property Rights related issues.
Shaheed Beheshti Medical University Snapshot
Shaheed Beheshti Medical University Overview
Key Information
Key Facts
Shaheed Beheshti Medical University – Research and Development Overview
Key Therapeutic Areas
Shaheed Beheshti Medical University – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Shaheed Beheshti Medical University – Pipeline Products Glance
Shaheed Beheshti Medical University – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Shaheed Beheshti Medical University Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Shaheed Beheshti Medical University – Drug Profiles
Avastin (Bevacizumab)
Product Description
Mechanism of Action
R&D Progress
Avastin + Triamcinolone
Product Description
Mechanism of Action
R&D Progress
Avastin_
Product Description
Mechanism of Action
R&D Progress
bevacizumab + triamcinolone acetonide
Product Description
Mechanism of Action
R&D Progress
Clindamycin + Dexamethasone
Product Description
Mechanism of Action
R&D Progress
Colchicine + Dexamethasone + Low Molecular Weight Heparin (LWH) + 5- Fluorouracil
Product Description
Mechanism of Action
R&D Progress
Doxycycline
Product Description
Mechanism of Action
R&D Progress
Influenza Vaccine
Product Description
Mechanism of Action
R&D Progress
Azithromycin
Product Description
Mechanism of Action
R&D Progress
Bevasizumab
Product Description
Mechanism of Action
R&D Progress
Cisplatin + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
Gemcitabine + Cisplatin + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
Triamcinolone
Product Description
Mechanism of Action
R&D Progress
Diclofenac
Product Description
Mechanism of Action
R&D Progress
Diclophenac
Product Description
Mechanism of Action
R&D Progress
Mitomycin C + Ahmed Glaucoma Valve
Product Description
Mechanism of Action
R&D Progress
Mitomycin C 0.02%
Product Description
Mechanism of Action
R&D Progress
Omeprazole
Product Description
Mechanism of Action
R&D Progress
Oxygen Therapy and Enalapril
Product Description
Mechanism of Action
R&D Progress
Pregabalin
Product Description
Mechanism of Action
R&D Progress
Roaccutane
Product Description
Mechanism of Action
R&D Progress
Shaheed Beheshti Medical University – Pipeline Analysis
Shaheed Beheshti Medical University – Pipeline Products by Therapeutic Class
Shaheed Beheshti Medical University Pipeline Products By Target
Shaheed Beheshti Medical University – Pipeline Products by Route of Administration
Shaheed Beheshti Medical University – Pipeline Products by Molecule Type
Shaheed Beheshti Medical University - Dormant Projects
Shaheed Beheshti Medical University – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
LIST OF TABLES
Shaheed Beheshti Medical University – Pipeline by Therapy Area and Indication, 2010
Shaheed Beheshti Medical University – Pipeline by Stage of Development, 2010
Shaheed Beheshti Medical University – Monotherapy Products in Pipeline, 2010
Shaheed Beheshti Medical University – Combination Treatment Modalities in Pipeline, 2010
Shaheed Beheshti Medical University – Phase III, 2010
Shaheed Beheshti Medical University - Phase II, 2010
Shaheed Beheshti Medical University - Phase I, 2010
Shaheed Beheshti Medical University - Pipeline By Therapeutic Class, 2010
Shaheed Beheshti Medical University - Pipeline By Target, 2010
Shaheed Beheshti Medical University – Pipeline By Route of Administration, 2010
Shaheed Beheshti Medical University – Pipeline By Molecule Type, 2010
Shaheed Beheshti Medical University - Dormant Developmental Projects, 2010 46
LIST OF FIGURES
Shaheed Beheshti Medical University – Pipeline by Therapy Area and Indication, 2010
Shaheed Beheshti Medical University – Pipeline by Stage of Development, 2010
Shaheed Beheshti Medical University – Monotherapy Products in Pipeline, 2010
Shaheed Beheshti Medical University – Combination Treatment Modalities in Pipeline, 2010
Shaheed Beheshti Medical University – Pipeline By Therapeutic Class, 2010
Shaheed Beheshti Medical University - Pipeline By Target, 2010
Shaheed Beheshti Medical University – Pipeline By Route of Administration, 2010
Shaheed Beheshti Medical University – Pipeline By Molecule Type, 2010 45
Shaheed Beheshti Medical University Overview
Key Information
Key Facts
Shaheed Beheshti Medical University – Research and Development Overview
Key Therapeutic Areas
Shaheed Beheshti Medical University – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Shaheed Beheshti Medical University – Pipeline Products Glance
Shaheed Beheshti Medical University – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Shaheed Beheshti Medical University Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Shaheed Beheshti Medical University – Drug Profiles
Avastin (Bevacizumab)
Product Description
Mechanism of Action
R&D Progress
Avastin + Triamcinolone
Product Description
Mechanism of Action
R&D Progress
Avastin_
Product Description
Mechanism of Action
R&D Progress
bevacizumab + triamcinolone acetonide
Product Description
Mechanism of Action
R&D Progress
Clindamycin + Dexamethasone
Product Description
Mechanism of Action
R&D Progress
Colchicine + Dexamethasone + Low Molecular Weight Heparin (LWH) + 5- Fluorouracil
Product Description
Mechanism of Action
R&D Progress
Doxycycline
Product Description
Mechanism of Action
R&D Progress
Influenza Vaccine
Product Description
Mechanism of Action
R&D Progress
Azithromycin
Product Description
Mechanism of Action
R&D Progress
Bevasizumab
Product Description
Mechanism of Action
R&D Progress
Cisplatin + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
Gemcitabine + Cisplatin + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
Triamcinolone
Product Description
Mechanism of Action
R&D Progress
Diclofenac
Product Description
Mechanism of Action
R&D Progress
Diclophenac
Product Description
Mechanism of Action
R&D Progress
Mitomycin C + Ahmed Glaucoma Valve
Product Description
Mechanism of Action
R&D Progress
Mitomycin C 0.02%
Product Description
Mechanism of Action
R&D Progress
Omeprazole
Product Description
Mechanism of Action
R&D Progress
Oxygen Therapy and Enalapril
Product Description
Mechanism of Action
R&D Progress
Pregabalin
Product Description
Mechanism of Action
R&D Progress
Roaccutane
Product Description
Mechanism of Action
R&D Progress
Shaheed Beheshti Medical University – Pipeline Analysis
Shaheed Beheshti Medical University – Pipeline Products by Therapeutic Class
Shaheed Beheshti Medical University Pipeline Products By Target
Shaheed Beheshti Medical University – Pipeline Products by Route of Administration
Shaheed Beheshti Medical University – Pipeline Products by Molecule Type
Shaheed Beheshti Medical University - Dormant Projects
Shaheed Beheshti Medical University – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
LIST OF TABLES
Shaheed Beheshti Medical University – Pipeline by Therapy Area and Indication, 2010
Shaheed Beheshti Medical University – Pipeline by Stage of Development, 2010
Shaheed Beheshti Medical University – Monotherapy Products in Pipeline, 2010
Shaheed Beheshti Medical University – Combination Treatment Modalities in Pipeline, 2010
Shaheed Beheshti Medical University – Phase III, 2010
Shaheed Beheshti Medical University - Phase II, 2010
Shaheed Beheshti Medical University - Phase I, 2010
Shaheed Beheshti Medical University - Pipeline By Therapeutic Class, 2010
Shaheed Beheshti Medical University - Pipeline By Target, 2010
Shaheed Beheshti Medical University – Pipeline By Route of Administration, 2010
Shaheed Beheshti Medical University – Pipeline By Molecule Type, 2010
Shaheed Beheshti Medical University - Dormant Developmental Projects, 2010 46
LIST OF FIGURES
Shaheed Beheshti Medical University – Pipeline by Therapy Area and Indication, 2010
Shaheed Beheshti Medical University – Pipeline by Stage of Development, 2010
Shaheed Beheshti Medical University – Monotherapy Products in Pipeline, 2010
Shaheed Beheshti Medical University – Combination Treatment Modalities in Pipeline, 2010
Shaheed Beheshti Medical University – Pipeline By Therapeutic Class, 2010
Shaheed Beheshti Medical University - Pipeline By Target, 2010
Shaheed Beheshti Medical University – Pipeline By Route of Administration, 2010
Shaheed Beheshti Medical University – Pipeline By Molecule Type, 2010 45
